TY - JOUR JO - EuroIntervention TI - Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial AB - <p class="text-paragraph" xml:lang='fr'><span class="bold">Aims: </span>Restenosis is higher among certain subpopulations when subjected to percutaneous coronary interventions even when using drug-eluting stents. The randomised SPIRIT II trial demonstrate AU - Khattab A. Ahmed AU - Richardt Gert AU - Verin V AU - Kelbæk Henning AU - Macaya Carlos AU - Berland Jacques AU - Miquel-Hebert Karine AU - Dorange Cécile AU - Serruys Patrick W. VL - 3 IS - 5 Y1 - 20/03/2008 Y1 - 2008 DOI - KW - restenosis KW - stent KW - eluting stent KW - everolimus KW - subgroups PB - Europa Digital & Publishing SE - Clinical research UR - https://eurointervention.pcronline.com/article/differentiated-analysis-of-an-everolimus-eluting-stent-and-a-paclitaxel-eluting-stent-among-higher-risk-subgroups-for-restenosis-results-from-the-spirit-ii-trial SN - 1774-024X ER -